Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia
Study Details
Study Description
Brief Summary
In this study, the investigator examined epidemiological and demographic characteristics, risk factors and 28-day mortality of patients admitted to the intensive care unit with the diagnosis of coronavirus disease 2019 pneumonia.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The patients with intensive care requirements were admitted from emergency department and coronavirus disease 2019 wards to our units. The criteria for intensive care requirement was identified as oxygen saturation<90%, partial oxygen pressure<70 mmHg, respiratory rate> 30/min or PaO2/FiO2(partial oxygen pressure/fraction of inspired oxygen) <300 despite conventional oxygen treatment of 5lt/min. Primary objective was the effect of defined data on 28-day mortality, and secondary objective was the impact of lymphocyte count, lactate dehydrogenase, ferritin, D-dimer and procalcitonin levels, and SOFA(Sequential Organ Failure Assessment) score on prognosis, which are among the risk factors determined by previous studies. All data were evaluated and recorded using the standardized International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) case report forms, complemented by electronic records of the hospital, nurse observation records, and missing information was completed by telephone interviews with patients' relatives.
Study Design
Outcome Measures
Primary Outcome Measures
- mortality [up to 28 days]
mortality rate
- demographic characteristics [up to 28 days]
Patients' age, gender, BMI, medical history
Eligibility Criteria
Criteria
Inclusion Criteria:
- The study was planned retrospectively, cross-sectionally and observationally with 193 patients hospitalized between 16 March 2020 and 15 May 2020 in five different coronavirus disease 2019 intensive care units in two campuses of our hospital.
Exclusion Criteria:
- Health workers, patients hospitalized less than 24 hours, patients with negative polymerase chain reaction tests, and patients who returned to intensive care unit after discharge were excluded from the study.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Sisli Etfal Research and Training Hospital | Istanbul | Marmara | Turkey | 34371 |
Sponsors and Collaborators
- Sisli Hamidiye Etfal Training and Research Hospital
Investigators
- Principal Investigator: ayse cinar, chief of anesthesia department
Study Documents (Full-Text)
More Information
Publications
None provided.- DM3334